Dynavax Technologies reported $83.38M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adma Biologics ADMA:US $ 111.59M 0.91M
Agenus AGEN:US $ -228.84M 61.78M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Amgen AMGN:US $ 8247M 1087M
AstraZeneca AZN:LN 15676M 1246M
Astrazeneca AZN:US $ 15676M 1246M
Biogen BIIB:US $ 10751.9M 69.7M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
BioSpecifics Technologies BSTC:US 135.31M 5.9M
Bristol Myers Squibb BMY:US $ 36808M 797M
Chimerix CMRX:US $ 119.15M 14.5M
Dynavax Technologies DVAX:US $ 83.38M 16.38M
Gilead Sciences GILD:US $ 19710M 758M
Glaxosmithkline GSK:US $ 15377M 512M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Idera Pharmaceuticals IDRA:US $ 37.73M 4.58M
Minerva Neurosciences NERV:US $ 36.17M 9.2M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Novartis NOVN:VX SF 54042M 3519M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Tg Therapeutics TGTX:US $ 383.13M 62.16M
Vertex Pharmaceuticals VRTX:US $ 9196.4M 216.14M